Alle News zum Sektor Gesundheit

Es sind 101 ETFs & Fonds zum Sektor Gesundheit bekannt.

Es sind 1530 Aktien zum Sektor Gesundheit bekannt.

>Alle News Gesundheit
- Top- News
- Alle News
- Branchenanalysen
- Aktienanalysen
- News zum Land A..
  - Afghanistan
  - Afrika
  - Albanien
  - Algerien
  - Angola
  - Argentinien
  - Armenien
  - Aserbaidschan
  - Asien
  - Australien
  - Australien & Ozeanien
- News zum Land B..
  - Bahamas
  - Bahrain
  - Bangladesch
  - Barbados
  - Belarus
  - Belgien
  - Belize
  - Benin
  - Bermuda
  - Bhutan
  - Bolivien
  - Bosnien und Herzegowina
  - Botswana
  - Brasilien
  - Britische Jungferninseln
  - Brunei
  - Bulgarien
  - Burkina Faso
  - Burundi
- News zum Land C..
  - Chile
  - China
  - Costa Rica
- News zum Land D..
  - Deutschland
  - Dominikanische Republik
  - Dschibuti
  - Dänemark
- News zum Land E..
  - Ecuador
  - El Salvador
  - Elfenbeinküste
  - Eritrea
  - Estland
  - Europa
- News zum Land F..
  - Fidschi
  - Finnland
  - Frankreich
- News zum Land G..
  - Gabun
  - Gambia
  - Georgien
  - Ghana
  - Griechenland
  - Großbritannien
  - Grönland
  - Guatemala
  - Guinea
  - Guyana
- News zum Land H..
  - Haiti
  - Honduras
  - Hong Kong (China)
- News zum Land I..
  - Indien
  - Indonesien
  - Irak
  - Iran
  - Irland
  - Island
  - Israel
  - Italien
- News zum Land J..
  - Jamaika
  - Japan
  - Jemen
  - Jordanien
- News zum Land K..
  - Kaimaninseln
  - Kambodscha
  - Kamerun
  - Kanada
  - Kasachstan
  - Katar
  - Kenia
  - Kirgisistan
  - Kolumbien
  - Kongo
  - Kosovo
  - Kroatien
  - Kuba
  - Kuwait
- News zum Land L..
  - Laos
  - Lateinamerika
  - Lesotho
  - Lettland
  - Libanon
  - Liberia
  - Libyen
  - Liechtenstein
  - Litauen
  - Luxemburg
- News zum Land M..
  - Madagaskar
  - Malawi
  - Malaysia
  - Mali
  - Marokko
  - Mauretanien
  - Mauritius
  - Mexiko
  - Moldau
  - Mongolei
  - Montenegro
  - Mosambik
  - Myanmar
- News zum Land N..
  - Naher Osten
  - Namibia
  - Nepal
  - Neuseeland
  - Nicaragua
  - Niederlande
  - Niger
  - Nigeria
  - Nordamerika
  - Nordkorea
  - Nordmazedonien
  - Norwegen
- News zum Land O..
  - Oman
  - Ostblock
  - Osttimor
- News zum Land P..
  - Pakistan
  - Palästina
  - Panama
  - Papua-Neuguinea
  - Paraguay
  - Peru
  - Philippinen
  - Polen
  - Portugal
- News zum Land R..
  - Ruanda
  - Rumänien
  - Russland
- News zum Land S..
  - Sambia
  - Saudi-Arabien
  - Schweden
  - Schweiz
  - Senegal
  - Serbien
  - Sierra Leone
  - Simbabwe
  - Singapur
  - Slowakei
  - Slowenien
  - Somalia
  - Spanien
  - Sri Lanka
  - Sudan
  - Syrien
  - Südafrika
  - Südkorea
- News zum Land T..
  - Tadschikistan
  - Taiwan (China)
  - Tansania
  - Thailand
  - Togo
  - Tschad
  - Tschechien
  - Tunesien
  - Turkmenistan
  - Türkei
- News zum Land U..
  - Uganda
  - Ukraine
  - Ungarn
  - Uruguay
  - USA
  - Usbekistan
- News zum Land V..
  - Venezuela
  - Vereinigte Arabische Emirate
  - Vietnam
- News zum Land Z..
  - Zentralafrikanische Republik
  - Zypern
- News zum Land Ä..
  - Ägypten
  - Äthiopien
- News zum Land Ö..
  - Österreich

13.10.26 - 03:00	CSL, Westpac, BHP shares: Buy, hold, or sell? (Fool)
	Find out what the experts tip for these ASX 200 giants. The post CSL, Westpac, BHP shares: Buy, hold, or sell? appeared first on The Motley Fool Australia....

13.10.26 - 02:36	Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm (PR Newswire)
	NEW YORK, Oct. 12, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of EXELIXIS, Inc. (NASDAQ: EXEL) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing.......

13.10.26 - 02:24	Buy, hold, sell: Wildcat Resources, Ramsay Health Care, CBA shares (Fool)
	The market is down on Tuesday as experts reveal insights into these three companies. The post Buy, hold, sell: Wildcat Resources, Ramsay Health Care, CBA shares appeared first on The Motley Fool Australia....

13.10.26 - 02:12	AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026? (Fool)
	AbbVie trades at a 40% valuation discount but faces revenue concentration risk, while Eli Lilly's cardiometabolic dominance commands a premium....

13.10.26 - 01:45	Abbott (ABT) Gains As Market Dips: What You Should Know (Zacks)
	Abbott (ABT) closed the most recent trading day at $101.82, moving +2.23% from the previous trading session....

13.10.26 - 01:45	CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know (Zacks)
	CRISPR Therapeutics AG (CRSP) closed at $51.55 in the latest trading session, marking a -3.45% move from the prior day....

13.10.26 - 01:24	Lumos Diagnostics appoints Tenmile Ventures representative to board as US commercialisation advances (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

13.10.26 - 01:15	Options traders pricing in 5% movement in UnitedHealth′s shares post earnings (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

13.10.26 - 01:00	Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today (Zacks)
	Bristol Myers Squibb (BMY) reached $57.6 at the closing of the latest trading day, reflecting a -2.58% change compared to its last close....

13.10.26 - 01:00	AbbVie (ABBV) Rises As Market Takes a Dip: Key Facts (Zacks)
	AbbVie (ABBV) reached $281.04 at the closing of the latest trading day, reflecting a +1.65% change compared to its last close....

13.10.26 - 00:21	ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit (PR Newswire)
	NEW YORK, Oct. 12, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff......

12.10.26 - 23:48	Droneshield vs Pro Medicus: Which is the better ASX growth stock right now? (Fool)
	Pro Medicus and Droneshield are both popular ASX growth shares, but only one stands out for quality and momentum right now. The post Droneshield vs Pro Medicus: Which is the better ASX growth stock right now? appeared first on The Motley Fool Australia....

12.10.26 - 23:45

Teva to Host R&D Day on Wednesday, November 11 in New York City (GlobeNewswire EN)

TEL AVIV, Israel, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will host an R&D Day on Wednesday, November 11, 2026. At the R&D Day, Teva's leadership will discuss its R&D pipeline, its near-term value-creation potential over the next five years, and Teva's ongoing transformation into an innovative biopharma company through the Pivot to Growth strategy....

12.10.26 - 23:21	J&J long-term Tremfya data demonstrates Crohn′s remission through three years (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.10.26 - 23:12	Buy, hold, sell: Mesoblast, Dicker Data, ASX shares (Fool)
	The drug maker is a standout among these companies. The post Buy, hold, sell: Mesoblast, Dicker Data, ASX shares appeared first on The Motley Fool Australia....

12.10.26 - 23:12	Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here′s Why I Think It Can Go Even Higher (Fool)
	Curaleaf looks eager to buy Aurora Cannabis, and that's helped to drive its value up....

12.10.26 - 22:51	LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026 (GlobeNewswire EN)
	BURLINGTON, Mass., Oct. 12, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2026 financial results on Wednesday, November 4, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook....

12.10.26 - 22:42	Syndax plummets as IPF asset axatilimab fails in phase 2 trial (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.10.26 - 22:39	ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett′s Esophagus (PR Newswire)
	Studies highlight how molecular risk assessment with TissueCypher can help inform surveillance and treatment decisions beyond biopsy findings alone FRIENDSWOOD, Texas, Oct. 12, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative......

12.10.26 - 22:33

USANA Schedules Third Quarter 2026 Earnings Release and Conference Call (Business Wire)

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that third quarter 2026 results will be released after the close of market on Tuesday, November 3, 2026. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, November 4, 2026 at 11:00 a.m. Eastern Time.The call will be broadcast over the Internet and can be accessed at http://ir.usana.com.About USANAUSANA develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold directly to Brand Partners and Preferred Customers across 25 global markets. More information on USANA can be found at www.usana.com. USANA also owns a 78.8% controlling ownership stake in Hiya ...

>weitere News anzeigen...